European Archives - Page 162 of 900 - European Medical Journal

Continue
15th August 2023

Diagnostic Odyssey of Myotonic Disorders

Diagnostic Odyssey of Myotonic Disorders. The publication of this infographic was supported by Lupin Neurosciences…
11 Mins
15th August 2023

Focal Onset Seizures: New Treatment Options in The Clinical Practice

Carreño began by discussing the spectrum of uncontrolled epilepsies. They stressed that uncontrolled epilepsy does not necessarily…
August 2023

EMJ Neurology 11.1 2023

Our latest issue of EMJ Neurology features a captivating array of peer-reviewed articles, exclusive interviews with renowned experts, and…
7 Mins
15th August 2023

Interview: Dirk Devroey

I undertook my university courses at University Hospitals, and at several other hospitals in Belgium, but I also had some training in…
5 Mins
15th August 2023

New EAN Guidelines: Diagnosing HyperCKaemia, Managing Amyotrophic Lateral Sclerosis, and Addressing Neurogenic Dysfunction

Theodoros Kyriakides, University of Nicosia, Cyprus, discussed the evolution of hyperCKaemia investigation, noting that…
9 Mins
15th August 2023

A Spotlight on Friedreich Ataxia: Optimising the Patient Journey from Diagnosis to Disease Management

Boesch explained that in the European Union (EU), a rare disease is defined as a disease that affects less than one person in 2,000…
1 Mins
15th August 2023

Sleep Features and Long-Term Incident Neurodegenerative Diseases: A Polysomnographic Study

The most prevalent neurodegenerative diseases (NDD) are Alzheimer’s disease and Parkinson’s disease, affecting 43.3 and…
15th August 2023

NfL as a Potential Biomarker in ATTRv Amyloidosis

NfL as a Potential Biomarker in ATTRv Amyloidosis. Publication of this infographic was supported and reviewed by Alnylam Pharmaceuticals…
4 Mins
15th August 2023

Neurodiversity in Brain Organisation

Mundorf explained that it is widely accepted that, in most individuals, the left hemisphere is dominant for language processing and speech…
6 Mins
15th August 2023

Development of the Clinical Myotonia Rating Scale and a Mexiletine Prescribing and Monitoring Algorithm for Patients with Non-Dystrophic Myotonia

In the rare neuromuscular disorders classed as NDM, muscle stiffness (myotonia) is the major symptom and is defined by a delayed muscle…